Recommended INN - List 64
rINN
benralizumab
condoliase
dalotuzumab
glembatumumab
mavrilimumab
moxetumomab pasudotox
secukinumab
sotatercept
suvizumab
tralokinumab
vonicog alfa
yttrium (
90
Y) clivatuzumab tetraxetan
▲
